Bleeding after receiving COVID-19 Vaccine
By Craig Paardekooper

2580007 (87.6%) of 2946448 women received at least one SARS-CoV-2 vaccination and 1652472(64.0%) 2580007 of vaccinated women received three doses before the end of follow-up.
The highest risks for bleeding in women who were postmenopausal were observed after the third
dose, in the one to seven days risk window (hazard ratio 1.28 (95% confidence interval 1.01 to 1.62))
and in the 8-90 days risk window (1.25 (1.04 to 1.50)). The impact of adjustment for covariates wasmodest.
Risk of postmenopausal bleeding suggested a 23-33% increased risk after 8-90 days with BNT162b2
and mRNA-1273 after the third dose

Large new study of 3 million women shows mRNA Covid jabs increased the risk of severe vaginal bleeds. Women 45
and over had a 23-33% higher risk of severe vaginal bleeding after receiving mRNA Covid shots, Swedish researchers
found.
The increased risk lasted for at least three months after women received a shot and was even higher after the third
shot than the first two. That finding suggests what scientists call a “dose-response relationship,” strong evidence thelink was not coincidence.
Because of its size and reliance on formal medical diagnoses rather than self-reporting of vaginal bleeding, thestudy offers strong evidence that the connection between Covid shots and bleeding is real.

Results for Effect on Menstrual Bleeding
1.6 Million Women Aged 12-49 Years
Here are the results for a population of 1,634,294 women aged 12 – 49 years old
It can be observed that for people currently menstruating, the incidence of menstrual disturbance per 100,000 in thevaccinated exceeded that in the unvaccinated by the following percentages after 8-90 days –Dose 1 : 2.8%
Dose 2 : 17.4%
Dose 3 : 35.6%

It appears that the initial effect of dose 1 tapers off after 7 days, since the incidence drops from 1106.2 down to 926
after 7 days. However dose 2 appears to restart the bleeding, and then it remains high. Dose 3 pushes it higher still.
Please note this sequential pattern –Dose 1

1-7 days

Upby 206

Dose 18-90 daysDown by 174

Dose 2

1-7 days

Upby 74

Dose 28-90 days

Upby 56

Dose 3

1-7 days

Upby 143

Dose 38-90 days

Upby 14

It is interesting that after dose 1 the body initially has a strong reaction, but then gradually recovers over 90 days
until it almost reaches the base line again. It looks as if the body was repairing the damage.
However, if a person takes a second dose then bleeding is restarted, and does not decrease. The body no longer
recovers as time passes. The damage is sustained.
If they take a third dose, then there is a significant jump upwards in bleeding. Once again, the body no longer
recovers as time passes. The damage is sustained.

So
Dose 1 triggers bleeding but the body recovers after 90 days
Dose 2 restarts bleeding and increases it back up to a level equivalent to the high level for dose 1
Dose 3 boosts bleeding above the previous highs.

Results for Effect on Menstrual Bleeding
664,201 Women in Primary Care, Aged 12-49 Years
Here are the results for a population of 446,270 women aged 12 – 49 years old, in primary care.

It appears that the initial effect of dose 1 tapers off after 7 days, since the incidence drops from 1635.9 down to1319.8 after 7 days. However dose 2 appears to restart the bleeding, and elevates it back up to 1553.2. Dose 3
pushes it higher still to 1678.4.

Comparing these graphs

In both cases, Dose 1 has an initial effect of increasing bleeding, but then the body fights back and repairs itself over
90 days. Dose 2 restarts the bleeding and elevates it to almost the same height as Dose 1, then Dose 3 carries ithigher still.

Results for Effects on Premenopausal Bleeding
1.6 Million Women Aged 12-49 Years

The results for pre-menopausal women bear a striking resemblance to those for menstruating womenOnce again, notice how the first dose elevates bleeding, but then the body recovers back to base line. The second
dose has a delayed effect – elevating the bleeding back up to approximately the maximum level achieved by dose 1.
It is the third dose that boosts bleeding far above these levels.

Results for Effects on Premenopausal Bleeding
664,201 Women Aged 12-49 Years, in Primary Care

The pattern is confirmed for premenopausal bleeding with women in primary care.

Notice, once again, that bleeding incidence is elevated after the first dose during the first 7 days. Then the body
recovers over the subsequent three months. However if someone takes a second dose, its effect is delayed, but
manifests over a three month period, elevating the incidence of bleeding back up to approximately the maximum
achieved by dose 1. Dose 3 boosts bleeding far above these levels.
Based on this common pattern, there can be absolutely no doubt that we are looking at a causal relationship. The
body struggles to repair the damage, but repeated injections restore the damage then compound it – resulting in asignificant increase in bleeding.
The same pattern applies to post-menopausal effects.

References

URGENT: Huge new study shows mRNA Covid jabs sharply raise the risk of severe vaginal bleeds (substack.com)
Association between SARS-CoV-2 vaccination and healthcare contacts for menstrual disturbance and bleeding in
women before and after menopause: nationwide, register based cohort study | The BMJ
https://howbad.info/bleedingnation.pdf